Andrey M. Osadchiy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Andrey M. Osadchiy has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
- Vyacheslav V. Semenyuta
Republican Clinical and Diagnostic Center
5 shared publications - Dmitriy Sergeevich Lebedev
Almazov National Medical Research Center
4 shared publications - Sergey G. Shcherbak
City Hospital №. 40
4 shared publications - A. V. Kamenev
Almazov National Medical Research Center
3 shared publications - Sergey V. Vlasenko
City Hospital № 40, St. Petersburg; Saint Petersburg State University
3 shared publications - D. A. Vorobyovskiy
City Hospital № 40 of Kurortny District; Saint Petersburg Institute of Bioregulation and Gerontology
2 shared publications
Latest Publications
- 26 January 2026
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 30 (2S)
Epidemiology, risk factors and diagnosis of chronic thromboembolic pulmonary hypertension: data from the registry
- 26 January 2026
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 30 (2S)
Epidemiology, risk factors and diagnosis of chronic thromboembolic pulmonary hypertension: data from the registry
- Open Access
- 14 March 2025
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 30 (2) , 5801
COVID-associated left atrial changes as a significant predictor of atrial fibrillation recurrence
Aim. To determine the prognostic significance of left atrial (LA) changes after SARS-CoV-2 infection on the atrial fibrillation recurrence rate after catheter ablation.Material and methods. The study involved 40 patients. All patients were monitored after 3, 6 and 12 months, as well as when the clinical performance of the disease changed. The average follow-up time was 19±3 months. Recurrence of atrial fibrillation was observed in 18 patients (45%).Results. The study groups were completely comparable in age (p=0,382), sex (p=0,604), arrhythmia type (p=0,842), and history of previous surgeries (p=0,949). Arrhythmia recurrence was 9,33 [2,18; 39,96] times more common in patients who had SARS-CoV-2 infection before surgery (p=0,01). Arrhythmia recurrence after catheter ablation caused by left atrial posterior wall fibrosis and without pulmonary vein reconnection is an independent risk factor for recurrence after another ablation attempt (p=0,020). Also, arrhythmia recurrence was 9 [2,09; 38,79] times more common in patients after left atrium posterior wall box isolation (p=0,002). About half of the atrial area in patients with arrhythmia recurrence is represented by myocardium with an amplitude of less than 0,25 mV. In patients without recurrence, the area with this amplitude is on average 15,9% smaller (49±18,4% and 33,1±17,5%, respectively; p=0,020). Differences in the myocardial area with an amplitude of less than 0,5 mV are more pronounced and average 21,4% (p=0,006). LA myocardial tissue with normal signal amplitude (>0,75 mV) is represented by only 17,4% of the area in patients with disease recurrence, which is 2,14 times less than in patients with remission (p=0,011).Conclusion. LA myocardial changes after SARS-CoV-2 infection are stable over time and significantly increase the arrhythmia recurrence risk after catheter ablation. Additional left atrial posterior wall box isolation does not reduce the risk of recurrence and does not significantly affect the duration of sinus rhythm control.
- 14 March 2025
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 30 (2) , 5801
Open AccessCOVID-associated left atrial changes as a significant predictor of atrial fibrillation recurrence
Aim. To determine the prognostic significance of left atrial (LA) changes after SARS-CoV-2 infection on the atrial fibrillation recurrence rate after catheter ablation.Material and methods. The study involved 40 patients. All patients were monitored after 3, 6 and 12 months, as well as when the clinical performance of the disease changed. The average follow-up time was 19±3 months. Recurrence of atrial fibrillation was observed in 18 patients (45%).Results. The study groups were completely comparable in age (p=0,382), sex (p=0,604), arrhythmia type (p=0,842), and history of previous surgeries (p=0,949). Arrhythmia recurrence was 9,33 [2,18; 39,96] times more common in patients who had SARS-CoV-2 infection before surgery (p=0,01). Arrhythmia recurrence after catheter ablation caused by left atrial posterior wall fibrosis and without pulmonary vein reconnection is an independent risk factor for recurrence after another ablation attempt (p=0,020). Also, arrhythmia recurrence was 9 [2,09; 38,79] times more common in patients after left atrium posterior wall box isolation (p=0,002). About half of the atrial area in patients with arrhythmia recurrence is represented by myocardium with an amplitude of less than 0,25 mV. In patients without recurrence, the area with this amplitude is on average 15,9% smaller (49±18,4% and 33,1±17,5%, respectively; p=0,020). Differences in the myocardial area with an amplitude of less than 0,5 mV are more pronounced and average 21,4% (p=0,006). LA myocardial tissue with normal signal amplitude (>0,75 mV) is represented by only 17,4% of the area in patients with disease recurrence, which is 2,14 times less than in patients with remission (p=0,011).Conclusion. LA myocardial changes after SARS-CoV-2 infection are stable over time and significantly increase the arrhythmia recurrence risk after catheter ablation. Additional left atrial posterior wall box isolation does not reduce the risk of recurrence and does not significantly affect the duration of sinus rhythm control.
- Open Access
- 1 November 2024
- Published by NII KPSSZ in Complex Issues of Cardiovascular Diseases
- Vol. 13 (3S) , 37-44
ALGORITHM FOR SELECTING PATIENTS FOR PULMONARY ARTERY ANGIOGRAPHY IN CASE OF SUSPECTED PULMONARY EMBOLISM
HighlightsWe have developed an algorithm for selecting patients for CT pulmonary angiography in case of suspected pulmonary embolism. The algorithm is based on the results of laboratory studies, duplex ultrasound of the veins of the lower extremities and echocardiography. This algorithm makes it possible to reliably exclude pulmonary embolism in 21.2% of patients without performing CT pulmonary angiography. Aim. To develop an algorithm for excluding pulmonary embolism and selecting patients for pulmonary angiography based on the results of laboratory and ultrasound studies.Methods. The retrospective single-center study was conducted using the data of 113 patients admitted to the ICU with suspected pulmonary embolism. Patients underwent echocardiography and duplex ultrasound of the veins of both lower extremities, and computed tomography pulmonary angiography with contrast.Results. We carried out comparative analysis of clinical and anamnestic data depending on the presence of pulmonary embolism. There were significant differences between the groups by gender (p = 0.008) and age (p = 0.042). The concentration of D-dimer in the group with pulmonary embolism was significantly higher than in the control group (p < 0.001). Moreover, the left ventricular ejection fraction was higher in the group with pulmonary embolism compared to controls (p < 0.001). According to ultrasound data, 59% of patients with pulmonary embolism showed signs of acute deep vein thrombosis of the lower extremities, which was significantly more common compared to the control group (p < 0.001).Pulmonary angiography should be recommended to patients with suspected pulmonary embolism and signs of prior or acute deep vein thrombosis. In the absence of these signs and a D-dimer concentration of less than 1 500 ng/mL, pulmonary embolism can be reliably excluded. In cases where the concentration of D-dimer is less than 10 000 ng/mL and pulmonary artery systolic pressure is no more than 30 mmHg, then pulmonary embolism can be excluded as well. In all other cases, we recommend to perform pulmonary angiography.Conclusion. We have developed an algorithm for excluding pulmonary embolism and selecting patients for pulmonary angiography. The algorithm makes it possible to increase the specificity of the study from 45.1% to 57.3%. The algorithm is based on the concentration of D-dimer and the results of noninvasive ultrasound diagnostics. Ultrasound examination of the deep veins of the lower extremities and echocardiography allow differential diagnosis of cardiac pathology and other causes of symptoms. Moreover, these methods can become the basis for the selection of patients for pulmonary angiography.
- 1 November 2024
- Published by NII KPSSZ in Complex Issues of Cardiovascular Diseases
- Vol. 13 (3S) , 37-44
Open AccessALGORITHM FOR SELECTING PATIENTS FOR PULMONARY ARTERY ANGIOGRAPHY IN CASE OF SUSPECTED PULMONARY EMBOLISM
HighlightsWe have developed an algorithm for selecting patients for CT pulmonary angiography in case of suspected pulmonary embolism. The algorithm is based on the results of laboratory studies, duplex ultrasound of the veins of the lower extremities and echocardiography. This algorithm makes it possible to reliably exclude pulmonary embolism in 21.2% of patients without performing CT pulmonary angiography. Aim. To develop an algorithm for excluding pulmonary embolism and selecting patients for pulmonary angiography based on the results of laboratory and ultrasound studies.Methods. The retrospective single-center study was conducted using the data of 113 patients admitted to the ICU with suspected pulmonary embolism. Patients underwent echocardiography and duplex ultrasound of the veins of both lower extremities, and computed tomography pulmonary angiography with contrast.Results. We carried out comparative analysis of clinical and anamnestic data depending on the presence of pulmonary embolism. There were significant differences between the groups by gender (p = 0.008) and age (p = 0.042). The concentration of D-dimer in the group with pulmonary embolism was significantly higher than in the control group (p < 0.001). Moreover, the left ventricular ejection fraction was higher in the group with pulmonary embolism compared to controls (p < 0.001). According to ultrasound data, 59% of patients with pulmonary embolism showed signs of acute deep vein thrombosis of the lower extremities, which was significantly more common compared to the control group (p < 0.001).Pulmonary angiography should be recommended to patients with suspected pulmonary embolism and signs of prior or acute deep vein thrombosis. In the absence of these signs and a D-dimer concentration of less than 1 500 ng/mL, pulmonary embolism can be reliably excluded. In cases where the concentration of D-dimer is less than 10 000 ng/mL and pulmonary artery systolic pressure is no more than 30 mmHg, then pulmonary embolism can be excluded as well. In all other cases, we recommend to perform pulmonary angiography.Conclusion. We have developed an algorithm for excluding pulmonary embolism and selecting patients for pulmonary angiography. The algorithm makes it possible to increase the specificity of the study from 45.1% to 57.3%. The algorithm is based on the concentration of D-dimer and the results of noninvasive ultrasound diagnostics. Ultrasound examination of the deep veins of the lower extremities and echocardiography allow differential diagnosis of cardiac pathology and other causes of symptoms. Moreover, these methods can become the basis for the selection of patients for pulmonary angiography.
- Open Access
- 17 October 2023
- Published by Arterialnaya Gipertenziya in Translational Medicine
- Vol. 10 (4) , 264-273
Results of myocardial revascularization in patients with acute coronary syndrome and COVID-19: experience of the urban multidisciplinary hospital
Background. The 2019 novel coronavirus pandemic has had a significant impact on the prognosis and outcomes of patients with acute coronary syndrome (ACS).Objective. Study of the impact of a new coronavirus infection (NCI) on the nature of the course and outcomes of the disease in patients with ACS.Materials and methods. The study included patients with ACS and a positive test for COVID-19 upon admission to the hospital in the period from April 2020 to August 2021.Results. The study included 107 patients. Among patients with and without ST elevation with more than 50 % lesions (n = 10; n = 10), 8 patients died, which was 80 % in each group. In the group with and without ST elevation with less than 50 % involvement (n = 20; n = 67), 5 and 8 patients died, accounting for 25 % and 11.9 %, respectively. The role of the influence of the levels of Il-6 (interleukin-6), troponin T and creatinine on the course and outcomes of the patients’ disease was analyzed.Conclusion. COVID-19 infection, namely the degree of damage to the lung tissue, significantly worsens the course and outcomes in patients with both NSTE-ACS and STE-ACS. Further accumulation of clinical experience in endovascular treatment of ACS and the development of algorithms for providing medical care to patients with ACS in the context of COVID-19 is required.
- 17 October 2023
- Published by Arterialnaya Gipertenziya in Translational Medicine
- Vol. 10 (4) , 264-273
Open AccessResults of myocardial revascularization in patients with acute coronary syndrome and COVID-19: experience of the urban multidisciplinary hospital
Background. The 2019 novel coronavirus pandemic has had a significant impact on the prognosis and outcomes of patients with acute coronary syndrome (ACS).Objective. Study of the impact of a new coronavirus infection (NCI) on the nature of the course and outcomes of the disease in patients with ACS.Materials and methods. The study included patients with ACS and a positive test for COVID-19 upon admission to the hospital in the period from April 2020 to August 2021.Results. The study included 107 patients. Among patients with and without ST elevation with more than 50 % lesions (n = 10; n = 10), 8 patients died, which was 80 % in each group. In the group with and without ST elevation with less than 50 % involvement (n = 20; n = 67), 5 and 8 patients died, accounting for 25 % and 11.9 %, respectively. The role of the influence of the levels of Il-6 (interleukin-6), troponin T and creatinine on the course and outcomes of the patients’ disease was analyzed.Conclusion. COVID-19 infection, namely the degree of damage to the lung tissue, significantly worsens the course and outcomes in patients with both NSTE-ACS and STE-ACS. Further accumulation of clinical experience in endovascular treatment of ACS and the development of algorithms for providing medical care to patients with ACS in the context of COVID-19 is required.
- Open Access
- 18 August 2023
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 28 (9) , 5512
COVID-19 as a potential trigger for refractory arrhythmias and electrical storm in a patient with dilated cardiomyopathy: a case report
Arrhythmias occur both in the acute coronavirus disease 2019 (COVID-19) and in the post-acute period, which may be associated with the long-term SARS-CoV-2 persistence. In a case report, patient with primary dilated cardiomyopathy, an implanted cardioverter-defibrillator, recurrent ventricular arrhythmias, and an electrical storm are presented. The patient was repeatedly hospitalized in a city hospital, where electrical cardioversion, antiarrhythmic therapy, radiofrequency ablation of recurrent ventricular tachycardia regions, including emergency ("lifesaving") combined catheter radiofrequency destruction of the electrical storm substrate, was performed. Subsequently, against the background of ongoing postoperative therapy, massive pulmonary embolism (PE) suddenly developed, which led to the death. Autopsy established that the cause of the patient’s death was massive pulmonary embolism; SARS-CoV-2 and enterovirus was detected in the myocardium. Based on an autopsy study, the patient was diagnosed with primary dilated cardiomyopathy with secondary active chronic lymphocytic myocarditis.
- 18 August 2023
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 28 (9) , 5512
Open AccessCOVID-19 as a potential trigger for refractory arrhythmias and electrical storm in a patient with dilated cardiomyopathy: a case report
Arrhythmias occur both in the acute coronavirus disease 2019 (COVID-19) and in the post-acute period, which may be associated with the long-term SARS-CoV-2 persistence. In a case report, patient with primary dilated cardiomyopathy, an implanted cardioverter-defibrillator, recurrent ventricular arrhythmias, and an electrical storm are presented. The patient was repeatedly hospitalized in a city hospital, where electrical cardioversion, antiarrhythmic therapy, radiofrequency ablation of recurrent ventricular tachycardia regions, including emergency ("lifesaving") combined catheter radiofrequency destruction of the electrical storm substrate, was performed. Subsequently, against the background of ongoing postoperative therapy, massive pulmonary embolism (PE) suddenly developed, which led to the death. Autopsy established that the cause of the patient’s death was massive pulmonary embolism; SARS-CoV-2 and enterovirus was detected in the myocardium. Based on an autopsy study, the patient was diagnosed with primary dilated cardiomyopathy with secondary active chronic lymphocytic myocarditis.
- Open Access
- 9 March 2023
- Published by Institute of Cardio Technics - INCART in Journal of Arrhythmology
- Vol. 30 (1) , 68-72
Simultaneous pulmonary vein isolation and ablation of the substrate of biatrial flutter in a patient with a mechanical mitral valve prosthesis: a case report
Случай одномоментной изоляции легочных вен и аблация субстрата биатриального трепетания у пациента с механическим протезом митрального клапана: клиническое наблюдение
- 9 March 2023
- Published by Institute of Cardio Technics - INCART in Journal of Arrhythmology
- Vol. 30 (1) , 68-72
Open AccessSimultaneous pulmonary vein isolation and ablation of the substrate of biatrial flutter in a patient with a mechanical mitral valve prosthesis: a case report
Случай одномоментной изоляции легочных вен и аблация субстрата биатриального трепетания у пациента с механическим протезом митрального клапана: клиническое наблюдение
- Open Access
- 22 February 2022
- Published by Arterialnaya Gipertenziya in Translational Medicine
- Vol. 8 (6) , 24-32
Endovascular occlusion of the left atrialaud in patients with atrial fibrillations. Experience of city hospital
Background. Endovascular occlusion of the left atrial appendage (LAA) using the Watchman device may be considered an adequate alternative to oral anticoagulant (OAC) administration in high-risk patients.Objective. To describe our experience with Watchman endovascular occlusion of the left atrial appendage in a city hospital setting in terms of feasibility and safety, as well as assess the short-term efficacy of this procedure.Design and methods. The study included patients who underwent implantation of the Watchman occlusion device from January 2016 to November 2020. The effectiveness of the procedure was defined as the ability to implant the Watchman without maintaining residual current, safety was defined as the occurrence of nosocomial and 45-day events including stroke, pericardial effusion, major bleeding, and device migration.Results. The study included 22 patients: 10 men and 12 women, who underwent implantation of the Watchman occluding device in the LAA. The indication for implantation was a history of gastrointestinal bleeding in 15 patients, cerebral hemorrhage in 3 patients and low compliance to therapy in 4 patients. The success rate of the procedure was 95.7 %. According to control transesophageal echocardiography, after 45 days LAA was excluded from the bloodstream in 21 of 22 patients.Conclusion. Despite the higher complication rate of occlusion of the LAA compared to drug treatment, the overall mortality from any cause in patients with the implanted Watchman was lower.
- 22 February 2022
- Published by Arterialnaya Gipertenziya in Translational Medicine
- Vol. 8 (6) , 24-32
Open AccessEndovascular occlusion of the left atrialaud in patients with atrial fibrillations. Experience of city hospital
Background. Endovascular occlusion of the left atrial appendage (LAA) using the Watchman device may be considered an adequate alternative to oral anticoagulant (OAC) administration in high-risk patients.Objective. To describe our experience with Watchman endovascular occlusion of the left atrial appendage in a city hospital setting in terms of feasibility and safety, as well as assess the short-term efficacy of this procedure.Design and methods. The study included patients who underwent implantation of the Watchman occlusion device from January 2016 to November 2020. The effectiveness of the procedure was defined as the ability to implant the Watchman without maintaining residual current, safety was defined as the occurrence of nosocomial and 45-day events including stroke, pericardial effusion, major bleeding, and device migration.Results. The study included 22 patients: 10 men and 12 women, who underwent implantation of the Watchman occluding device in the LAA. The indication for implantation was a history of gastrointestinal bleeding in 15 patients, cerebral hemorrhage in 3 patients and low compliance to therapy in 4 patients. The success rate of the procedure was 95.7 %. According to control transesophageal echocardiography, after 45 days LAA was excluded from the bloodstream in 21 of 22 patients.Conclusion. Despite the higher complication rate of occlusion of the LAA compared to drug treatment, the overall mortality from any cause in patients with the implanted Watchman was lower.
- Open Access
- 8 August 2021
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 26 (7) , 4526
Electroanatomic substrate of atrial fibrillation in patients after COVID-19
Aim. To determine the features of left atrial electroanatomic structure and the arrhythmia substrate in patients with atrial fibrillation (AF) after coronavirus disease 2019 (COVID-19).Material and methods. The pilot study included 20 patients with AF who underwent catheter radiofrequency ablation. Ten patients had COVID-19 and 10 patients were included as a control group. AF substrate was identified using anatomic and bipolar mapping. Zones with following amplitudes were analyzed: Results. The groups were homogeneous in AF type, number of patients after prior pulmonary vein isolation, and heart rate during mapping. In the COVID-19 group, there was a higher area of fibrous zones with an amplitude of Conclusion. This study shows that SARS-CoV-2 infection may cause left atrial remodeling in the form of diffuse fibrosis. The arrhythmia substrate in patients after COVID-19 can be localized not only in pulmonary vein mouths, but also in other left atrial areas. This must be taken into account before ablation, even if the procedure is being performed for the first time. It is recommended to perform amplitude mapping for all patients who have had SARS-CoV-2 infection in order to identify fibrous zones and plan the operation extent.
- 8 August 2021
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 26 (7) , 4526
Open AccessElectroanatomic substrate of atrial fibrillation in patients after COVID-19
Aim. To determine the features of left atrial electroanatomic structure and the arrhythmia substrate in patients with atrial fibrillation (AF) after coronavirus disease 2019 (COVID-19).Material and methods. The pilot study included 20 patients with AF who underwent catheter radiofrequency ablation. Ten patients had COVID-19 and 10 patients were included as a control group. AF substrate was identified using anatomic and bipolar mapping. Zones with following amplitudes were analyzed: Results. The groups were homogeneous in AF type, number of patients after prior pulmonary vein isolation, and heart rate during mapping. In the COVID-19 group, there was a higher area of fibrous zones with an amplitude of Conclusion. This study shows that SARS-CoV-2 infection may cause left atrial remodeling in the form of diffuse fibrosis. The arrhythmia substrate in patients after COVID-19 can be localized not only in pulmonary vein mouths, but also in other left atrial areas. This must be taken into account before ablation, even if the procedure is being performed for the first time. It is recommended to perform amplitude mapping for all patients who have had SARS-CoV-2 infection in order to identify fibrous zones and plan the operation extent.